[1] Williams JP,Yamamoto S,Raman SS,et al. Percutaneous ablation of hepatocellular carcinoma:current status. J Vasc Interv Radiol, 2010,21（Suppl 8）:S204-213.
[2] 薛平,郑超,曹良启,等. 超声联合腹腔镜射频消融术对肝癌患者免疫功能的影响.临床医学工程,2012,19（10）:1637-1640.
[3] 扈彩霞,郑加生,钱智玲,等. 原发性肝癌患者射频消融前后外周血T淋巴细胞绝对值变化的临床意义.北京医学,2011,33 : 451-453.
[4] Shiina S,Tateishi R,Arano T,et al. Radiofrequency ablation for hepatocellular carcinoma：10-year outcome and prognostic factors.Am J Gastroenterol,2012,107：569-577.
[5] 邱少敏,彭鹏,宋玉华,等. 肝癌患者血清趋化因子配体18 的检测及其意义.现代生物医学进展,2012,12（22）：4275-4280.
[6] 中国抗癌协会肝癌专业委员会.原发性肝癌的临床诊断与分期标准.中华肝胆病杂志,2001,12（9）：324-325.
[7] Neumann-Haefelin C,Btam HE,Chisari FV,et al.T cell responge in hepatitis C virus infection.J Clin Virol,2005,32（2）：75-85.
[8] Alessandro Z,Massimo P,Amalia P,et al.Radiofrequency thermal ablation of hepatoeellular carcinoma liver nodules responses.Cancer Res,2006,66（23）：1139-1146.
[9] Salama IA,Korayem E,ElAbd O,et al. Laparoscopic ultrasound with radiofrequency ablation of hepatic tumors in cirrhotic patients. J Laparoendosc Adv Surg Tech,2010,20（1）：39-46.
[10] Simo KA,Sereika SE,Newton KN,et al. Laparoscopic-assisted microwave ablation for hepatocellular carcinoma：safety and efficacy in comparison with radiofrequency ablation. J Surg Oncol,2011,104（7）：822-829.
[11] Eishiro M,Yasunari N,Kuniaki A,et al. Enhancement of tumor-specific T-cell responses by transcatheter arterial embolization with dendritic cell infusion for hepatocellular carcinoma. Int J Cancer,2010,126（9）：2164-2174.
[12] Widenmeyer M,Shebzukhov Y,Haen SP,et al. Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablation. Int J Cancer,2011,128（11）：2653-2662.
[13] Shimomura S,Ikeda N,Saito M,et al. Long-term interferon therapy after radiofrequency ablation is effective in treating patients with HCV-associated hepatocellular carcinoma. Hepatol Int,2010,5 （1）：559-566. |
